Aptazapine maleate

This classification denotes the maleate form of an antidepressant agent with the molecular structure C16H19N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 240J927J1R chemically known as (+/-)-1,3,4,14b-tetrahydro-2-methyl-2h,10h-pyrazino(1,2-a)pyrrolo(2,1-c)(1,4)benzodiazepine, but more commonly known as aptazapine, which bears US NIH Compound Identifier 51355. European Medicines Agency schedules Aptazapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05547MIG. The term APTAZAPINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations, for tariff and trade purposes, schedule aptazapine maleate under HS 29335995 and SITC 51576. As of Q4 2014, APTAZAPINE MALEATE remains US FDA's Preferred Term for this commodity. Aptazapine maleate bears US NLM identifiers UMLS ID C2698177 and NCI Concept Code C79726. SMILES: CN1CCN2C3CCCCC3CN4CCCC4C2C1.C(=C\C(=O)O)\C(=O)O.